Acrivon Therapeutics, Inc.

Develops precision cancer therapies by matching patients to drugs using its proteomics platform.

ACRV | NDAQ

Overview

Corporate Details

ISIN(s):: US0048901096
LEI:
Country:: United States of America
Address:: 480 ARSENAL WAY, SUITE 100, 2472 WATERTOWN
Website:: https://acrivon.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Acrivon Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in precision oncology. The company leverages its proprietary Acrivon Predictive Precision Proteomics (AP3) platform to develop targeted cancer therapies. The AP3 platform utilizes phosphoproteomics to analyze the biologic drivers of a patient's cancer, enabling the creation of predictive 'OncoSignature' tests. This method is designed to match drug candidates with patients whose tumors are most likely to respond, aiming to improve therapeutic outcomes beyond what is achievable with genomics. Acrivon's pipeline is led by ACR-368, a selective kinase inhibitor in Phase 2 clinical trials for various solid tumors. The company also advances its internally developed programs and seeks strategic partnerships to apply its AP3 platform to co-develop predictive tests for external drug candidates.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Acrivon Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Acrivon Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Acrivon Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
GRAIL, Inc. A biotech company that detects multiple cancers early with a single blood test.	United States of America	GRAL
Greatland Resources Limited A gold and copper producer operating and developing mines in Western Australia's Paterson region.	Australia	GGP
Groupe CRIT International provider of human resources, airport assistance, and industrial services.	France	CEN
Gubra A/S CRO & biotech accelerating peptide drug discovery for metabolic and fibrotic diseases.	Denmark	GUBRA
HACKETT GROUP, INC. IP-based strategic advisory on Gen AI and digital transformation for global enterprises.	United States of America	HCKT
HALOZYME THERAPEUTICS, INC. Licenses a drug delivery platform to biopharma, converting IV drugs to subcutaneous injections.	United States of America	HALO
HANATOUR JAPAN CO.,LTD. B2C/B2B travel firm providing packages, MICE, and inbound services, with a focus on Korea.	Japan	6561
HANATOUR SERVICE INC. South Korea's top travel firm offering package tours and custom trips for B2C & B2B clients.	South Korea	039130
Hanmi Science Co.,Ltd A holding company managing R&D-focused pharmaceutical, API, and medical device firms.	South Korea	008930
Haoxi Health Technology Ltd An online marketing solutions provider for the healthcare industry, focusing on video and news feed ads.	United States of America	HAO